Amgen實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

Amgen 新聞

盧昕穎 2026 Mar 26, 00:00

伊朗霍爾木茲海峽「校準策略」引擔憂:全球石油市場低估供應短缺風險

陳昊然 2026 Mar 26, 00:00

美元展望:地緣政治與經濟增長擔憂下的抉擇

張瑋庭 2026 Mar 26, 00:00

四月美股反彈潛力:空頭回補與技術性催化劑將推動漲勢

盧昕穎 2026 Mar 25, 00:00

地緣政治風險與儲備多元化趨勢推動 央行持續購入黃金

林芷柔 2026 Mar 25, 00:00

歐洲基地:美對伊朗行動的隱形後勤支柱

黃達傑 2025 Oct 09, 16:00

臺灣值得關注的加密貨幣:比特幣(BTC)、以太坊(ETH)、索拉納(Solana,SOL)、零幣(Zcash,ZEC)

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

最新新聞

顯示更多
張瑋庭 2026 Mar 26, 00:00

伊朗局勢前夕市場異動頻頻 內幕交易疑雲籠罩

陳昊然 2026 Mar 26, 00:00

黃金的動盪時刻:地緣政治衝突考驗避險地位

陳昊然 2026 Mar 26, 00:00

燃油價飆漲與伊朗戰事爭議拖累 川普支持率創任內新低

張瑋庭 2026 Mar 26, 00:00

伊以空襲交鋒加劇,美國外交訊號顯現矛盾

盧昕穎 2026 Mar 26, 00:00

加、挪趁中東能源危機擴大油氣出口,鞏固盟友供應鏈

陳昊然 2026 Mar 26, 00:00

美聯儲大樓翻修案:檢方承認證據不足,削弱特朗普指控

盧昕穎 2026 Mar 26, 00:00

散戶情緒轉變:市場動態變遷的訊號

陳昊然 2026 Mar 26, 00:00

伊朗衝突加劇土耳其外匯儲備承壓:黃金干預一觸即發?

聯絡方式

點差

2.25

點差(%)

0.6382 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

187827339264

流通股份

539067675

收益日期(下一個)

1999-11-22

現金殖利率 

2026-06-05

除息日

2026-05-15

遠期年股息率

10.08

遠期年現金殖利率

0.0289

每股盈餘

14.22

了解有關此金融工具的詳細資訊

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
林芷柔 2025 Oct 29, 16:00

進階交易策略:多頭部位 vs. 空頭部位,哪個更好?

黃達傑 2025 Oct 13, 16:00

Palantir(PLTR)股價預測:PLTR暴跌5%,Palantir股價會再度飆升嗎?

黃達傑 2025 Oct 13, 16:00

Nvidia(NVDA)股價今日走高:2026年目標價是多少?

Trustpilot